Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

Diabetes

Volumn 50, Issue 5, 2001, Pages 1126-1133

  Hotta, Kikuko ^a   Funahashi, Tohru ^a   Bodkin, Noni L ^b   Ortmeyer, Heidi K ^b   Arita, Yukio ^a   Hansen, Barbara C ^b   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CELL PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HYPERINSULINEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RHESUS MONKEY;

EID: 0035039227     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.5.1126     Document Type: Article

References (41)

1. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances
2. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
3. Leptin: The tale of an obesity gene
4. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
5. Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: Usefulness of leptin for the treatment of obesity-associated diabetes
6. Pathophysiological role of leptin in obesity-related hypertension
7. Chronic leptin infusion increases arterial pressure
8. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats
9. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity
10. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus
11. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients-relationship with plasma insulin
12. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1)
13. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma
14. Paradoxical decrease of an adipose-specific protein adiponectin, in obesity
15. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls
16. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin
17. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
18. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway
19. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages
20. Heterogeneity of insulin responses: Phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey
21. Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys
22. β-Cell hyperresponsiveness: Earliest event in development of diabetes in monkeys
23. Central obesity in rhesus monkeys: Association with hyperinsulinemia, insulin resistance and hypertriglyceridemia?
24. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
25. Studies on body composition. IV. Use of radioactive hydrogen for measurement in vivo of total body water
26. Regulation of obese (ob) mRNA and plasma leptin levels in rhesus monkeys: Effects of insulin, body weight, and non-insulin-dependent diabetes mellitus
27. Hyperleptinemia: Relationship to adiposity and insulin resistance in the spontaneously obese rhesus monkey
28. Regulation of contractile protein gene family mRNA pool sizes during myogenesis
29. Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes
30. Adipose tissue glycogen synthase activation by in vivo insulin in spontaneously insulin-resistant and type 2 (non-insulin-dependent) diabetic rhesus monkeys
31. Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys
32. Adipose tissue as an endocrine and paracrine organ
33. Role of adipose tissue in body-weight regulation: Mechanisms regulating leptin production and energy balance
34. A novel serum protein similar to C1q, produced exclusively in adipocytes
35. Effects of tumor necrosis factor α on leptin secretion and gene expression: Relationship to changes of glucose metabolism in isolated rat adipocytes
36. Tumour necrosis factor-α exerts dual effects on human adipose leptin synthesis and release
37. Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: Effect of tumor necrosis factor-α and transforming growth factor-β1
38. Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes
39. Effect of tumor necrosis factor α and transforming growth factor β 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture
40. Tumor necrosis factor-α inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans
41. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats